NewsBlog:
    [Entry posted at 1st December 2008 04:25 PM GMT]
    The European Patent Office (EPO) issued its final ruling last week rejecting a much-contested embryonic stem cell patent -- a decision that will likely be cheered by researchers and jeered by biotechs.

    The patent covered technology developed by James Thomson, a University of Wisconsin researcher, to culture primate embryonic stem cells derived from pre-implantation embryos. In last week's ruling, the EPO upheld a previous decision, made last... Click to continue

    Comment on this blog



Previous months
>>   December 2008
>>   November 2008
>>   October 2008
>>   September 2008
>>   August 2008
>>   July 2008
>>   June 2008
>>   May 2008
>>   April 2008
>>   March 2008
>>   February 2008
>>   January 2008
>>   December 2007
>>   November 2007
>>   October 2007
>>   September 2007
>>   August 2007
>>   July 2007
>>   June 2007
>>   May 2007
>>   April 2007
>>   March 2007
>>   February 2007
>>   January 2007
>>   December 2006
>>   November 2006
>>   October 2006
>>   September 2006
>>   August 2006
>>   July 2006
>>   June 2006
>>   May 2006
>>   April 2006
>>   March 2006
>>   February 2006
>>   January 2006
>>   December 2005
>>   November 2005
>>   October 2005
>>   September 2005
>>   August 2005
>>   July 2005
>>   June 2005